Endoscopic treatment of vesicoureteral reflux with dextranomer/ hyaluronic acid-our experience
Objectives: We report our experience with subureteral submucosal injection therapy for vesicoureteral reflux and determine the safety and efficacy in patients treated with dextranomer/ hyaluronic acid co-polymer. Background: Vesicoureteral reflux affects 1% of children and increases the chances of...
Main Authors: | Prasad Mylarappa, Prathvi, Puvvada Sandeep, Kailash B. Banale, D. Ramesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Al Ameen Medical College
2013-07-01
|
Series: | Al Ameen Journal of Medical Sciences |
Subjects: | |
Online Access: | http://ajms.alameenmedical.org/ArticlePDFs/14%20AJMS%20V6.N3.2013%20p%20260-264.pdf |
Similar Items
-
Does Autologous Blood Injection Following Dextranomer/Hyaluronic Acid Copolymer Implantation in Treating Vesicoureteral Reflux Affect the Microsphere Particle Leakage?
by: Hooman Kamran, et al.
Published: (2024-02-01) -
The treatment of vesicoureteral reflux in children by endoscopic sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid: A case-series, multi-centre study
by: Osama Bawazir
Published: (2017-04-01) -
Endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer and dextranomer/hyaluronic acid in adults
by: Akif Turk, et al.
Published: (2014-06-01) -
SUBURETERAL MUCOSA INJECTION WITH DETRANOMER/HYALURONIC ACID FOR VESICOURETERAL REFLUX TREATMENT: SYSTEMATIC REVIEW
by: Nicholas Tambunan, et al.
Published: (2017-03-01) -
Endoscopic Treatment of Vesicoureteral Reflux: Changing Trends Over the Years
by: Taner Ceylan, et al.
Published: (2021-06-01)